Skip to content

Prospective Multicenter Cohort Study Evaluating the Incidence and Risk Factors for Problem Gambling Among Young Adults With First-episode Psychosis

A Better Understanding of the Association Between Problem Gambling and Psychotic Disorders in Young Adults: a New Path Towards Recovery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05686772
Acronym
ANTE-UP
Enrollment
520
Registered
2023-01-17
Start date
2019-11-01
Completion date
2023-05-01
Last updated
2025-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gambling Disorder, Psychotic Disorders

Keywords

Gambling, Psychotic disorder, Schizophrenia, Cohort, Multicenter, Prospective, Observational, Incidence, Risk factors

Brief summary

The aims of this propsective cohort study are to get a better understanding of the association between problem gambling and psychotic disorders among young adults with first-episode psychosis. The main questions to be answered are: 1. What is the incidence of problem gambling in this population? 2. What are the predictors of problem gambling in this population? To do so, putative predictors of problem gambling will be analyzed using Cox regression models: * Sociodemographics (e.g., age, gender identity, ethnicity, level of education, employment); * Psychiatric comorbidities (e.g., substance use disorders, cluster B personality disorders); * Antipsychotic use (first/second-generation, third-generation \[aripiprazole, brexpiprazole, cariprazine\]); * Prior gambling history.

Detailed description

All Cox regression models will be adjusted for site-effect. Further multivariable models will be constructed to examine the association between antipsychotic use (as continuous exposure) and incident PBG using the directed acyclic graphs approach to adjust for confounders.

Interventions

DRUGAntipsychotic use

Use of first/second generation antipsychotics, use of third-generation antipsychotics, use of aripiprazole specifically

OTHERPsychiatric comorbidities

Substance use disorders, cluster B personality disorders, anxiety disorder, major depressive disorder, attention-deficit/hyperactivity disorder, tobacco smoking

OTHERSociodemographics/socioeconomic status

Age, gender identity, ethnicity, highest educational attainment, employment, at school, homelessness, in a relationship

OTHERGambling history

Non-problematic gambling at the time of admission and/or previous 12 months

Main psychiatric diagnosis, history of psychiatric hospitalizations, severity of illness (CGI-S), functioning (SOFAS), concomitant psychotropic medications use

Sponsors

Fonds de la Recherche en Santé du Québec
CollaboratorOTHER_GOV
Laval University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

* 18 to 35 years old; * Diagnosis of first-episode psychosis (i.e., DSM-5 diagnosis of schizophrenia spectrum and other psychotic disorders, as well as DSM-5 bipolar disorder with psychotic features).

Exclusion criteria

* Active/prior PBG at te time of admission; * Loss to follow-up within first three months; * DSM-5 diagnosis of psychotic disorder due to a medical condition; * Severe intellectual disability.

Design outcomes

Primary

MeasureTime frameDescription
Problem gamblingOutcome assessed at every 6-month time point, from patients admission until the first occurrence of the primary outcome, loss to follow-up, or May 1, 2023.i) Diagnosis of gambling disorder according to DSM-5 criteria, established by the treating psychiatrist, and/or; ii) Problem gambling according to a score of 8 and more on the Problem Gambling Severity Index, as questioned by the clinical case manager and/or treating psychiatrist

Other

MeasureTime frameDescription
Sensitivity analysis restricted to DSM-5 gambling disorderOutcome assessed at every 6-month time point, from patients admission until the first occurrence of the primary outcome, loss to follow-up, or May 1, 2023.DSM-5 diagnosis of gambling disorder by treating psychiatrist

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026